Vasilios Kalas

819 total citations
15 papers, 593 citations indexed

About

Vasilios Kalas is a scholar working on Endocrinology, Epidemiology and Molecular Biology. According to data from OpenAlex, Vasilios Kalas has authored 15 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Vasilios Kalas's work include Escherichia coli research studies (10 papers), Urinary Tract Infections Management (6 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). Vasilios Kalas is often cited by papers focused on Escherichia coli research studies (10 papers), Urinary Tract Infections Management (6 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). Vasilios Kalas collaborates with scholars based in United States, Singapore and Iran. Vasilios Kalas's co-authors include Scott J. Hultgren, Jerome S. Pinkner, Karen Dodson, James W. Janetka, Laurel Mydock‐McGrane, Swaine L. Chen, Roger D. Klein, Drew J. Schwartz, Michael E. Hibbing and Caitlin N. Spaulding and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Vasilios Kalas

14 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasilios Kalas United States 12 319 221 185 81 80 15 593
Steven M. Denkin United States 12 306 1.0× 150 0.7× 240 1.3× 86 1.1× 39 0.5× 14 685
Varun Khanna France 14 529 1.7× 47 0.2× 167 0.9× 36 0.4× 35 0.4× 26 826
Simon Kleeb Switzerland 6 230 0.7× 163 0.7× 94 0.5× 148 1.8× 78 1.0× 8 442
Carolina Trujillo United States 15 587 1.8× 32 0.1× 366 2.0× 41 0.5× 65 0.8× 23 985
Cressida A. Madigan United States 10 415 1.3× 193 0.9× 220 1.2× 16 0.2× 39 0.5× 14 868
James A. D. Good Sweden 13 188 0.6× 65 0.3× 84 0.5× 122 1.5× 40 0.5× 17 571
Nathan Haseley United States 7 309 1.0× 65 0.3× 143 0.8× 12 0.1× 106 1.3× 8 572
Doo Ri An South Korea 10 222 0.7× 33 0.1× 134 0.7× 29 0.4× 55 0.7× 14 425
Nathanael A. Caveney United States 13 255 0.8× 57 0.3× 40 0.2× 48 0.6× 46 0.6× 25 581
Emma Byres Australia 11 275 0.9× 110 0.5× 62 0.3× 34 0.4× 19 0.2× 14 526

Countries citing papers authored by Vasilios Kalas

Since Specialization
Citations

This map shows the geographic impact of Vasilios Kalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasilios Kalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasilios Kalas more than expected).

Fields of papers citing papers by Vasilios Kalas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasilios Kalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasilios Kalas. The network helps show where Vasilios Kalas may publish in the future.

Co-authorship network of co-authors of Vasilios Kalas

This figure shows the co-authorship network connecting the top 25 collaborators of Vasilios Kalas. A scholar is included among the top collaborators of Vasilios Kalas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasilios Kalas. Vasilios Kalas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Venanzio, Gisela Di, Jerome S. Pinkner, Karen Dodson, et al.. (2023). Structure–function correlates of fibrinogen binding by Acinetobacter adhesins critical in catheter-associated urinary tract infections. Proceedings of the National Academy of Sciences. 120(4). e2212694120–e2212694120. 14 indexed citations
2.
Kalas, Vasilios, et al.. (2021). Paraneoplastic Thrombocytopenia. The American Journal of Medicine. 134(8). 976–979.
3.
Brown, Jeffrey W., Koushik K. Das, Vasilios Kalas, Kiron M. Das, & Jason C. Mills. (2021). mAb Das-1 recognizes 3’-Sulfated Lewis A/C, which is aberrantly expressed during metaplastic and oncogenic transformation of several gastrointestinal Epithelia. PLoS ONE. 16(12). e0261082–e0261082. 9 indexed citations
4.
Brown, Jeffrey W., Koushik K. Das, Vasilios Kalas, Kiron M. Das, & Jason C. Mills. (2021). 368 3’-SULFATED LEWIS A IS A BIOMARKER FOR METAPLASTIC AND CARCINOMATOUS TRANSFORMATION OF SEVERAL GASTROINTESTINAL EPITHELIA. Gastroenterology. 160(6). S–71. 2 indexed citations
5.
Hibbing, Michael E., Karen Dodson, Vasilios Kalas, Swaine L. Chen, & Scott J. Hultgren. (2020). Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat. mBio. 11(5). 14 indexed citations
6.
Kalas, Vasilios, Michael E. Hibbing, Jerome S. Pinkner, et al.. (2018). Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection. Proceedings of the National Academy of Sciences. 115(12). E2819–E2828. 70 indexed citations
7.
Klein, Roger D., et al.. (2018). Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design. Journal of Medicinal Chemistry. 62(2). 467–479. 24 indexed citations
8.
Kalas, Vasilios, Jerome S. Pinkner, Thomas J. Hannan, et al.. (2017). Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Science Advances. 3(2). e1601944–e1601944. 52 indexed citations
9.
Conover, Matt S., Ségolène Ruer, Joemar Taganna, et al.. (2016). Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection. Cell Host & Microbe. 20(4). 482–492. 55 indexed citations
10.
Mydock‐McGrane, Laurel, Zachary Cusumano, Zhenfu Han, et al.. (2016). Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections. Journal of Medicinal Chemistry. 59(20). 9390–9408. 97 indexed citations
11.
Han, Zhenfu, Vasilios Kalas, Roger D. Klein, et al.. (2016). Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI. ChemMedChem. 11(4). 367–373. 56 indexed citations
12.
Schwartz, Drew J., Vasilios Kalas, Jerome S. Pinkner, et al.. (2013). Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proceedings of the National Academy of Sciences. 110(39). 15530–15537. 105 indexed citations
13.
Liang, Wenguang, Vasilios Kalas, Robert J. Hoey, et al.. (2013). Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme. Proceedings of the National Academy of Sciences. 110(34). 13827–13832. 48 indexed citations
14.
Volkan, Ender, Vasilios Kalas, Jerome S. Pinkner, et al.. (2013). Molecular basis of usher pore gating in Escherichia coli pilus biogenesis. Proceedings of the National Academy of Sciences. 110(51). 20741–20746. 18 indexed citations
15.
Ralat, Luis A., et al.. (2010). Ubiquitin Is a Novel Substrate for Human Insulin-Degrading Enzyme. Journal of Molecular Biology. 406(3). 454–466. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven M. Denkin Breakdown of academic impact, for papers by Varun Khanna Breakdown of academic impact, for papers by Simon Kleeb Breakdown of academic impact, for papers by Carolina Trujillo Breakdown of academic impact, for papers by Cressida A. Madigan Breakdown of academic impact, for papers by James A. D. Good Breakdown of academic impact, for papers by Nathan Haseley Breakdown of academic impact, for papers by Doo Ri An Breakdown of academic impact, for papers by Nathanael A. Caveney Breakdown of academic impact, for papers by Emma Byres
Rankless by CCL
2026